Search results for: 'ami global'

This outlook identifies the trends shaping the global pharmaceutical landscape. The growth of the global pharmaceutical industry will plateau in 2023 due to a slowdown of the biologics segment as a result of a decrease in the uptake of COVID-19 vaccines and therapeutics. Market growth will be low in the United States and Europe and highest in the A...

This market insight discusses the rheumatoid arthritis pharmaceutical drugs currently in the global market as well as those in the development stage. It offers a competitive analysis of the drugs and a forecast of their impact on the market. Drugs in the development stage are segmented by clinical trial phase as well as by drug class. The study cov...

Numerous facilities, ranging from research laboratories to hospitals, academic centers and commercial entities, collect human tissues and biomaterials. This study will discuss opportunities, challenges and forecasts for the biobanking automation market globally for the period 2010-2018. Varying requirements of biobanks have urged market participant...

The treatment of rare diseases requires the use of specialized drugs. Patient populations for rare diseases are most often quite small, consequently the products treating them earn the designation orphan drugs. These drugs must undergo the research, development, and clinical trials that all drugs do, yet the investment into the development is great...

19 Oct 2021  |  Global  |  Market Research

Global Orthopedics Growth Opportunities

Transformational Growth Driven by Digital Solutions is Shaping the Future of Orthopedics

Infographics

×

Key Benefits

The global orthopedic implant market is in the midst of a transformation. With enhanced research, product development is improving to suit patient requirements and support more successful surgical outcomes. The growth potential for orthopedic implants is more in emerging markets than in mature ones. This study provides revenue forecasts, market sha...

01 Mar 2024  |  North America  |  Market Research

Global Orphan Drug Growth Opportunities

Reduced Exclusivity and Increased Competition will Drive Demand for More Efficient R&D and Digital Solutions

Infographics

×

In this study, Frost & Sullivan s Transformational Health team provides critical insights into the global orphan drug (OD) industry and highlights growth opportunities, revenue, regulatory changes, and technology trends influencing growth. Approximately 5% of rare diseases (RDs) have received US FDA approval for a drug, while up to 15% of RDs have ...

This research service provides an overview of the global cardiac monitoring devices market. The geographical scope of this global study is North America (NA), Europe, and Asia-Pacific (APAC). It offers a detailed analysis of market sizing, trends, competitive landscape, future market outlook by region, and growth opportunities. The market is segmen...

With increased interest in precision medicine and demand for telemedicine and digital solutions in hospitals and laboratories, digital pathology has the opportunity to grow in its clinical, pharma, and research applications. Advances in AI-based algorithms and data management and analysis software offer immense potential in improving workflow, aut...

The Global Cancer Therapeutics Market is a fast growing market that is relying heavily on new drugs. The total therapeutic market is expected to grow from $23.1 billion in 2004 to $60.6 billion in 2011. The targeted therapy segment is providing the growth of the entire market with an expected compound annual growth rate of 24.1 percent for 2004-2...